Jonathan C. Dudley

3.4k total citations · 1 hit paper
24 papers, 1.5k citations indexed

About

Jonathan C. Dudley is a scholar working on Oncology, Cancer Research and Molecular Biology. According to data from OpenAlex, Jonathan C. Dudley has authored 24 papers receiving a total of 1.5k indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Oncology, 11 papers in Cancer Research and 9 papers in Molecular Biology. Recurrent topics in Jonathan C. Dudley's work include Cancer Genomics and Diagnostics (10 papers), Pancreatic and Hepatic Oncology Research (5 papers) and Colorectal Cancer Treatments and Studies (4 papers). Jonathan C. Dudley is often cited by papers focused on Cancer Genomics and Diagnostics (10 papers), Pancreatic and Hepatic Oncology Research (5 papers) and Colorectal Cancer Treatments and Studies (4 papers). Jonathan C. Dudley collaborates with scholars based in United States, Taiwan and Australia. Jonathan C. Dudley's co-authors include Ming‐Tseh Lin, James R. Eshleman, Dung T. Le, Martha B. Pitman, A. John Iafrate, Long P. Le, Maximilian Diehn, Aadel A. Chaudhuri, Christopher D. Gocke and Li‐Hui Tseng and has published in prestigious journals such as Journal of Clinical Oncology, Blood and Nature Biotechnology.

In The Last Decade

Jonathan C. Dudley

23 papers receiving 1.5k citations

Hit Papers

Microsatellite Instability as a Biomarker for PD-1 Blockade 2016 2026 2019 2022 2016 200 400 600

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jonathan C. Dudley United States 15 937 625 495 475 380 24 1.5k
Russell W. Madison United States 24 799 0.9× 538 0.9× 900 1.8× 265 0.6× 466 1.2× 105 1.6k
Priyanka Shivdasani United States 9 661 0.7× 357 0.6× 664 1.3× 253 0.5× 412 1.1× 11 1.4k
Andrea Lampis Italy 18 702 0.7× 655 1.0× 567 1.1× 337 0.7× 655 1.7× 38 1.7k
Jon Chung United States 25 1.0k 1.1× 677 1.1× 720 1.5× 424 0.9× 765 2.0× 109 2.0k
Martina Kirchner Germany 18 701 0.7× 505 0.8× 497 1.0× 119 0.3× 307 0.8× 59 1.2k
Takashi Hojo Japan 19 669 0.7× 755 1.2× 179 0.4× 202 0.4× 354 0.9× 76 1.4k
Ana De Jesus‐Acosta United States 21 1.4k 1.5× 567 0.9× 395 0.8× 266 0.6× 600 1.6× 76 1.9k
Zachary R. Chalmers United States 15 584 0.6× 349 0.6× 580 1.2× 152 0.3× 649 1.7× 35 1.4k
R. J. Cote United States 7 669 0.7× 645 1.0× 365 0.7× 364 0.8× 420 1.1× 9 1.4k
Stacey Stein United States 18 802 0.9× 327 0.5× 387 0.8× 260 0.5× 315 0.8× 74 1.4k

Countries citing papers authored by Jonathan C. Dudley

Since Specialization
Citations

This map shows the geographic impact of Jonathan C. Dudley's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jonathan C. Dudley with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jonathan C. Dudley more than expected).

Fields of papers citing papers by Jonathan C. Dudley

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jonathan C. Dudley. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jonathan C. Dudley. The network helps show where Jonathan C. Dudley may publish in the future.

Co-authorship network of co-authors of Jonathan C. Dudley

This figure shows the co-authorship network connecting the top 25 collaborators of Jonathan C. Dudley. A scholar is included among the top collaborators of Jonathan C. Dudley based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jonathan C. Dudley. Jonathan C. Dudley is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Argani, Pedram, Ezra Baraban, Oksana Yaskiv, et al.. (2025). Clinically Sporadic Folliculin-mutated Renal Epithelial Neoplasms Represent a Mixture of True Somatic Folliculin-mutated and Occult Birt-Hogg-Dubé Syndrome-associated Cases. The American Journal of Surgical Pathology. 49(9). 859–872. 4 indexed citations
2.
Suvarnapathaki, Sanika, et al.. (2024). Unlocking the Potential of Circulating miRNAs as Biomarkers in Glioblastoma. Life. 14(10). 1312–1312. 1 indexed citations
3.
Christenson, Eric S., Hua‐Ling Tsai, Dung T. Le, et al.. (2023). Colorectal cancer in patients of advanced age is associated with increased incidence of BRAF p.V600E mutation and mismatch repair deficiency. Frontiers in Oncology. 13. 1193259–1193259. 10 indexed citations
4.
Cohen, Joshua D., Christopher Douville, Jonathan C. Dudley, et al.. (2021). Detection of low-frequency DNA variants by targeted sequencing of the Watson and Crick strands. Nature Biotechnology. 39(10). 1220–1227. 44 indexed citations
5.
Rosenbaum, Matthew W., Ronald Arpin, Brenna Casey, et al.. (2020). Cytomorphologic characteristics of next-generation sequencing–positive bile duct brushing specimens. Journal of the American Society of Cytopathology. 9(6). 520–527. 7 indexed citations
6.
Chin, R, Abul Usmani, Peter K. Harris, et al.. (2019). Detection of Solid Tumor Molecular Residual Disease (MRD) Using Circulating Tumor DNA (ctDNA). Molecular Diagnosis & Therapy. 23(3). 311–331. 126 indexed citations
7.
Dudley, Jonathan C., Joseph G. Schroers‐Martin, Daniel Lazzareschi, et al.. (2018). Detection and Surveillance of Bladder Cancer Using Urine Tumor DNA. Cancer Discovery. 9(4). 500–509. 151 indexed citations
8.
Aalipour, Amin, Jonathan C. Dudley, Seung Min Park, et al.. (2017). Deactivated CRISPR Associated Protein 9 for Minor-Allele Enrichment in Cell-Free DNA. Clinical Chemistry. 64(2). 307–316. 31 indexed citations
9.
Chaudhuri, Aadel A., Jacob J. Chabon, Alexander F. Lovejoy, et al.. (2017). Analysis of circulating tumor DNA in localized lung cancer for detection of molecular residual disease and personalization of adjuvant strategies.. Journal of Clinical Oncology. 35(15_suppl). 8519–8519. 4 indexed citations
10.
Dudley, Jonathan C., Ming‐Tseh Lin, Dung T. Le, & James R. Eshleman. (2016). Microsatellite Instability as a Biomarker for PD-1 Blockade. Clinical Cancer Research. 22(4). 813–820. 674 indexed citations breakdown →
11.
Dudley, Jonathan C., Tad J. Wieczorek, Martin K. Selig, et al.. (2016). Clinicopathological characteristics of invasive gastric Helicobacter pylori. Human Pathology. 61. 19–25. 9 indexed citations
12.
Lin, Ming‐Tseh, Li‐Hui Tseng, Jonathan C. Dudley, et al.. (2015). A Novel Tandem Duplication Assay to Detect Minimal Residual Disease in FLT3/ITD AML. Molecular Diagnosis & Therapy. 19(6). 409–417. 8 indexed citations
13.
Dudley, Jonathan C., Li‐Hui Tseng, Lisa M. Rooper, et al.. (2015). Challenges Posed to Pathologists in the Detection of KRAS Mutations in Colorectal Cancers. Archives of Pathology & Laboratory Medicine. 139(2). 211–218. 33 indexed citations
14.
Zheng, Zongli, Jessica Wang, Jonathan C. Dudley, et al.. (2015). Impact of next-generation sequencing on the clinical diagnosis of pancreatic cysts. Gastrointestinal Endoscopy. 83(1). 140–148. 108 indexed citations
15.
Dudley, Jonathan C., Zongli Zheng, Thomas O. McDonald, et al.. (2015). Next-Generation Sequencing and Fluorescence in Situ Hybridization Have Comparable Performance Characteristics in the Analysis of Pancreaticobiliary Brushings for Malignancy. Journal of Molecular Diagnostics. 18(1). 124–130. 69 indexed citations
16.
Haley, Lisa, Li‐Hui Tseng, Gang Zheng, et al.. (2015). Performance characteristics of next-generation sequencing in clinical mutation detection of colorectal cancers. Modern Pathology. 28(10). 1390–1399. 45 indexed citations
17.
Carter, Jamal, Li‐Hui Tseng, Gang Zheng, et al.. (2015). Non-p.V600E BRAF Mutations Are Common Using a More Sensitive and Broad Detection Tool. American Journal of Clinical Pathology. 144(4). 620–628. 38 indexed citations
18.
Chen, Guoli, Jonathan C. Dudley, Li‐Hui Tseng, et al.. (2014). Lymph node metastases of melanoma: challenges for BRAF mutation detection. Human Pathology. 46(1). 113–119. 14 indexed citations
19.
Dudley, Jonathan C., Grzegorz T. Gurda, Li‐Hui Tseng, et al.. (2014). Tumor Cellularity as a Quality Assurance Measure for Accurate Clinical Detection of BRAF Mutations in Melanoma. Molecular Diagnosis & Therapy. 18(4). 409–418. 27 indexed citations
20.
Perkins, Archibald S., et al.. (2008). EVI1 Blocks Apoptosis in DA-1 Myeloid Leukemia Cells Via Enhanced Transcription of the Prosurvival Gene Bcl2a1 (A1). Blood. 112(11). 3805–3805. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026